GlassScriptPhysician profile
Tsung Mou
NPI 1235524752
$9,760.10
in general payments reported to CMS, 2019-2025
14 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $312 · 2020: $69.17 · 2021: $1,318 · 2022: $418 · 2023: $7,021 · 2024: $446 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Travel and Lodging: $2,263 · Food and Beverage: $1,309 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Travel and Lodging | $2,263.49 |
| Food and Beverage | $1,309.31 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,350.46 | 2021-2023 | Da Vinci Surgical System |
| Axonics, INC. | $2,939.66 | 2021-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $650.34 | 2019-2025 | Axonics, Solyx Sis System |
| Abbvie INC. | $224.39 | 2023-2024 | |
| Medtronic USA, INC. | $131.73 | 2019 | |
| Coloplast Corp | $118.12 | 2023 | Altis |
| Astellas Pharma US INC | $87.71 | 2022-2023 | |
| Applied Medical Resources Corporation | $55.44 | 2022 | |
| Medtronic, INC. | $49.11 | 2021-2022 | |
| Convatec INC. | $43.57 | 2023 | |
| Hologic Sales and Service, LLC | $42.15 | 2024 | Aptima, Thinprep 2000 Processor |
| Minerva Surgical, INC | $26.07 | 2024 | |
| Baxter Healthcare | $25.33 | 2021 | |
| Merck Sharp & Dohme LLC | $16.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tsung Mou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.